0.93
price down icon7.92%   -0.08
 
loading

NanoViricides Inc 주식(NNVC)의 최신 뉴스

pulisher
Feb 12, 2026

Small cap wrap: BioVie, VivoPower, NanoViricides, Aftermath Silver... - Proactive financial news

Feb 12, 2026
pulisher
Feb 12, 2026

NanoViricides seeks FDA orphan status for MPox drug - Proactive financial news

Feb 12, 2026
pulisher
Feb 12, 2026

MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides - Bitget

Feb 12, 2026
pulisher
Feb 12, 2026

New Mpox drug candidate NV-387 chases FDA orphan status - Stock Titan

Feb 12, 2026
pulisher
Feb 12, 2026

NanoViricides Files for Orphan Drug Status as U.S. Measles Cases Surge (MRNA,QNCX) - Barchart.com

Feb 12, 2026
pulisher
Feb 10, 2026

NanoViricides Comments on the Need for Broad-Spectrum Antivirals in Light of the Current Influenza WaveNV-387 is Effective Against H3N2 - Ventura County Star

Feb 10, 2026
pulisher
Feb 10, 2026

Small cap wrap: Medicus Pharma, 1911 Gold, NanoViricides, Nextech3D.ai, NextSource Materials… - Proactive Investors

Feb 10, 2026
pulisher
Feb 10, 2026

Measles cases surge as NanoViricides seeks orphan status for NV-387 - Stock Titan

Feb 10, 2026
pulisher
Feb 10, 2026

NanoViricides seeks orphan drug status with US FDA for measles treatment - Proactive financial news

Feb 10, 2026
pulisher
Feb 09, 2026

NanoViricides President Dr. Diwan Interviewed by Mission Matters’ Adam Torres - USA Today

Feb 09, 2026
pulisher
Feb 07, 2026

Trading Recap: Is NanoViricides Inc part of any ETFJuly 2025 Drop Watch & Real-Time Buy Signal Alerts - baoquankhu1.vn

Feb 07, 2026
pulisher
Feb 05, 2026

CEO Change: Is NanoViricides Inc undervalued by DCF analysisWeekly Stock Recap & Safe Entry Zone Identification - baoquankhu1.vn

Feb 05, 2026
pulisher
Feb 03, 2026

NanoViricides President Discusses Broad-Spectrum Antiviral Platform and Upcoming Phase II Trial for MPox Treatment - citybuzz -

Feb 03, 2026
pulisher
Feb 02, 2026

NanoViricides President Dr. Diwan Interviewed by Mission Matters' Adam Torres - accessnewswire.com

Feb 02, 2026
pulisher
Jan 29, 2026

Can NanoViricides Inc. continue delivering strong returnsJuly 2025 Momentum & Weekly Watchlist for Consistent Profits - mfd.ru

Jan 29, 2026
pulisher
Jan 28, 2026

Can NanoViricides Inc continue delivering strong returnsQuarterly Growth Report & Fast Exit and Entry Strategy Plans - baoquankhu1.vn

Jan 28, 2026
pulisher
Jan 24, 2026

NanoViricides, Inc. Has Filed its Quarterly ReportSubsequent Raise Has Fortified Fiscal Position - Hattiesburg American

Jan 24, 2026
pulisher
Jan 24, 2026

NanoViricides to Present at the 3rd Annual DealFlow Discovery Conference - chronicle-tribune.com

Jan 24, 2026
pulisher
Jan 23, 2026

NanoViricides Announces Closing of $6 Million Registered Direct Offering and Concurrent Private Placement Priced at the Market Close - hattiesburgamerican.com

Jan 23, 2026
pulisher
Jan 23, 2026

NanoViricides Has Signed a Master Services Agreement with OnlyOrphansCote Regarding Orphan Drug Strategy of NV-387 for Treatment of MPox, Smallpox, and Measles - Hattiesburg American

Jan 23, 2026
pulisher
Jan 22, 2026

ETF Watch: Should I hold or sell NanoViricides Inc nowJuly 2025 Chart Watch & AI Powered Market Entry Ideas - baoquankhu1.vn

Jan 22, 2026
pulisher
Jan 17, 2026

Aug Momentum: Is NanoViricides Inc forming a bullish divergenceTrade Analysis Summary & Risk Adjusted Buy/Sell Alerts - baoquankhu1.vn

Jan 17, 2026
pulisher
Jan 16, 2026

Support Test: Should I invest in NanoViricides Inc before earningsJuly 2025 PostEarnings & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn

Jan 16, 2026
pulisher
Jan 15, 2026

Jobs Data: How much upside does NanoViricides Inc have2025 Bull vs Bear & Long-Term Capital Growth Strategies - baoquankhu1.vn

Jan 15, 2026
pulisher
Jan 13, 2026

NanoViricides Highlights Need for Broad-Spectrum Antivirals During Severe Influenza Season - citybuzz -

Jan 13, 2026
pulisher
Jan 13, 2026

NanoViricides highlights need for broad-spectrum antivirals amid severe flu season - Proactive financial news

Jan 13, 2026
pulisher
Jan 13, 2026

San Gabriel Valley Tribune - FinancialContent

Jan 13, 2026
pulisher
Jan 13, 2026

Options Flow: Will NanoViricides Inc. stock continue dividend increases2025 Winners & Losers & Short-Term Swing Trade Alerts - Bộ Nội Vụ

Jan 13, 2026
pulisher
Jan 12, 2026

Market Recap: Can NanoViricides Inc NV3P stock sustain institutional flowsInflation Watch & Stock Portfolio Risk Control - Bộ Nội Vụ

Jan 12, 2026
pulisher
Jan 11, 2026

After-Hours Rally: Zentalis, LifeMD, And NanoViricides Among Top Gainers - Nasdaq

Jan 11, 2026
pulisher
Jan 10, 2026

Published on: 2026-01-10 19:47:32 - ulpravda.ru

Jan 10, 2026
pulisher
Jan 10, 2026

Volume Summary: Will NanoViricides Inc NV3P stock outperform small cap peersJuly 2025 Chart Watch & Reliable Breakout Forecasts - moha.gov.vn

Jan 10, 2026
pulisher
Jan 10, 2026

NanoViricides Has Received Approval to Start Phase II Clinical Trial of NV-387 for the Treatment of MPox by the Regulatory Agency ACOREP of the Democratic Republic of Congo - patriotledger.com

Jan 10, 2026
pulisher
Jan 10, 2026

Can NanoViricides Inc. stock outperform in 2025 bull marketJuly 2025 Weekly Recap & Reliable Price Action Trade Plans - Улправда

Jan 10, 2026
pulisher
Jan 09, 2026

Can NanoViricides Inc. stock hit record highs againPortfolio Update Summary & Expert Curated Trade Setup Alerts - Улправда

Jan 09, 2026
$44.80
price up icon 1.24%
$26.75
price down icon 0.19%
$100.75
price up icon 1.93%
$105.76
price down icon 3.31%
$146.17
price down icon 1.52%
biotechnology ONC
$346.42
price down icon 1.38%
자본화:     |  볼륨(24시간):